MeSH term
Frequency | Condition_Probility | Animals | 47 | 0.0 |
Charcot-Marie-Tooth Disease/*genetics/pathology | 6 | 42.0 |
Comparative Study | 21 | 0.0 |
Gene Expression | 7 | 0.0 |
Humans | 251 | 0.0 |
Mice | 29 | 0.0 |
Myelin Proteins/*genetics | 42 | 40.0 |
Myelin Sheath/physiology | 2 | 11.0 |
Research Support, Non-U.S. Gov't | 193 | 0.0 |
Axons/physiology | 2 | 4.0 |
Charcot-Marie-Tooth Disease/genetics/*physiopathology | 3 | 100.0 |
Disease Progression | 6 | 0.0 |
Myelin Proteins/genetics | 25 | 46.0 |
Adolescent | 42 | 0.0 |
Adult | 72 | 0.0 |
Child | 45 | 0.0 |
Electrophysiology | 20 | 4.0 |
Female | 122 | 0.0 |
Male | 116 | 0.0 |
Middle Aged | 52 | 0.0 |
Motor Neurons/physiology | 3 | 6.0 |
Neural Conduction/*physiology | 3 | 15.0 |
Prospective Studies | 4 | 0.0 |
Charcot-Marie-Tooth Disease/*diagnosis/genetics | 5 | 100.0 |
*Chromosomes, Human, Pair 17 | 57 | 11.0 |
*Gene Deletion | 9 | 1.0 |
Genetic Markers | 23 | 0.0 |
Pedigree | 68 | 0.0 |
Pregnancy | 7 | 0.0 |
Charcot-Marie-Tooth Disease/*genetics | 80 | 57.0 |
Gene Dosage | 12 | 3.0 |
Gene Duplication | 19 | 12.0 |
Point Mutation/genetics | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 68 | 0.0 |
Magnetic Resonance Imaging | 3 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Microscopy, Electron | 10 | 0.0 |
Mutation/genetics | 5 | 0.0 |
Cohort Studies | 5 | 0.0 |
Connexins/genetics | 11 | 24.0 |
DNA Mutational Analysis | 18 | 0.0 |
DNA Primers | 4 | 0.0 |
Family Health | 8 | 0.0 |
Genotype | 12 | 0.0 |
Myelin P0 Protein/genetics | 7 | 46.0 |
Phenotype | 28 | 0.0 |
*Point Mutation | 10 | 0.0 |
Transcription Factors/genetics | 2 | 0.0 |
Age Factors | 3 | 0.0 |
DNA Mutational Analysis/methods | 2 | 0.0 |
Disease Models, Animal | 11 | 0.0 |
Myelin Proteins/genetics/metabolism | 2 | 50.0 |
Aged | 32 | 0.0 |
Aged, 80 and over | 5 | 0.0 |
Likelihood Functions | 2 | 1.0 |
Logistic Models | 2 | 0.0 |
Diagnosis, Differential | 2 | 0.0 |
Sensitivity and Specificity | 3 | 0.0 |
Mutation/*genetics | 3 | 0.0 |
Myelin Proteins/*genetics/metabolism | 5 | 83.0 |
DNA/chemistry | 2 | 0.0 |
Hamsters | 3 | 0.0 |
Promoter Regions (Genetics)/*genetics | 3 | 0.0 |
Amino Acid Sequence | 13 | 0.0 |
Charcot-Marie-Tooth Disease/*genetics/*physiopathology | 4 | 44.0 |
Child, Preschool | 29 | 0.0 |
Infant | 8 | 0.0 |
Linkage (Genetics)/genetics | 2 | 0.0 |
Molecular Sequence Data | 44 | 0.0 |
Neural Conduction/genetics | 3 | 33.0 |
Retrospective Studies | 2 | 0.0 |
Sex Factors | 5 | 0.0 |
X Chromosome/*genetics | 2 | 0.0 |
Base Sequence | 36 | 0.0 |
Brain Stem/physiopathology | 2 | 25.0 |
Charcot-Marie-Tooth Disease/*genetics/pathology/physiopathology | 5 | 55.0 |
Linkage (Genetics) | 16 | 0.0 |
Mutation | 16 | 0.0 |
Neural Conduction/physiology | 3 | 7.0 |
Peripheral Nerves/physiopathology | 5 | 35.0 |
Reflex/physiology | 2 | 11.0 |
Myelin Proteins/biosynthesis/*genetics | 2 | 50.0 |
Myelin Sheath/*metabolism | 2 | 5.0 |
Sequence Homology, Nucleic Acid | 3 | 0.0 |
Transfection | 4 | 0.0 |
Gene Deletion | 13 | 0.0 |
*Gene Dosage | 3 | 3.0 |
Norway | 2 | 1.0 |
Polymerase Chain Reaction | 23 | 0.0 |
Recombination, Genetic/*genetics | 2 | 2.0 |
Genes, Dominant | 11 | 1.0 |
Heterozygote | 11 | 0.0 |
Luminescent Measurements | 2 | 2.0 |
Molecular Biology/*methods | 2 | 8.0 |
Nucleic Acid Hybridization | 5 | 0.0 |
Reference Values | 4 | 0.0 |
Animals, Genetically Modified | 5 | 2.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Rats | 6 | 0.0 |
Sural Nerve/ultrastructure | 2 | 28.0 |
*Chromosome Deletion | 5 | 0.0 |
Chromosomes, Human, Pair 17/genetics | 10 | 5.0 |
*Evolution, Molecular | 2 | 0.0 |
*Gene Duplication | 15 | 10.0 |
Hereditary Motor and Sensory Neuropathies/*genetics | 18 | 41.0 |
Physical Chromosome Mapping | 2 | 0.0 |
Recombination, Genetic | 9 | 0.0 |
Exons | 9 | 0.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Charcot-Marie-Tooth Disease/diagnosis/*genetics | 5 | 41.0 |
Hereditary Motor and Sensory Neuropathies/diagnosis/*genetics | 2 | 66.0 |
Charcot-Marie-Tooth Disease/*physiopathology | 5 | 83.0 |
Mutation/physiology | 2 | 1.0 |
Reaction Time | 3 | 2.0 |
Asian Continental Ancestry Group/genetics | 2 | 0.0 |
Chromosomes, Human, Pair 17 | 31 | 9.0 |
European Continental Ancestry Group/genetics | 2 | 0.0 |
Tandem Repeat Sequences | 2 | 1.0 |
Electromyography | 6 | 3.0 |
Neurologic Examination | 2 | 1.0 |
Chromosome Banding | 7 | 0.0 |
Chromosome Mapping | 43 | 0.0 |
Chromosomes, Human, Pair 17/*genetics | 9 | 5.0 |
DNA/analysis | 4 | 0.0 |
In Situ Hybridization, Fluorescence | 22 | 0.0 |
Microsatellite Repeats | 4 | 0.0 |
Syndrome | 9 | 0.0 |
Connexins/*genetics | 6 | 3.0 |
Peripheral Nervous System Diseases/*genetics | 10 | 40.0 |
Polymorphism, Genetic | 6 | 0.0 |
Sural Nerve/pathology | 6 | 14.0 |
3T3 Cells | 3 | 0.0 |
Cosmids | 2 | 0.0 |
*Recombination, Genetic | 8 | 2.0 |
*Repetitive Sequences, Nucleic Acid | 10 | 2.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 6 | 0.0 |
Action Potentials/physiology | 2 | 4.0 |
Axons/*pathology | 3 | 20.0 |
Charcot-Marie-Tooth Disease/*pathology/*physiopathology | 2 | 100.0 |
Linkage (Genetics)/*genetics | 3 | 1.0 |
Lod Score | 6 | 0.0 |
Microsatellite Repeats/genetics | 3 | 0.0 |
Neurofilament Proteins/*genetics | 2 | 13.0 |
Polymorphism, Single-Stranded Conformational | 4 | 0.0 |
Cell Line | 3 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
Sequence Analysis, DNA | 6 | 0.0 |
Transcription Factors/metabolism | 2 | 0.0 |
DNA Mutational Analysis/*methods | 3 | 2.0 |
DNA-Binding Proteins/*genetics | 3 | 0.0 |
Myelin P0 Protein/*genetics | 7 | 24.0 |
Transcription Factors/*genetics | 2 | 0.0 |
Charcot-Marie-Tooth Disease/genetics | 10 | 41.0 |
Polymerase Chain Reaction/methods | 4 | 0.0 |
Genetic Screening | 4 | 0.0 |
Demyelinating Diseases/genetics | 3 | 75.0 |
X Chromosome/genetics | 2 | 1.0 |
Blotting, Western | 3 | 0.0 |
Case-Control Studies | 4 | 0.0 |
Cell Differentiation | 3 | 0.0 |
Cell Division | 2 | 0.0 |
Gene Expression Regulation | 3 | 0.0 |
Myelin P0 Protein/metabolism | 2 | 50.0 |
Abnormalities, Multiple/*genetics | 3 | 0.0 |
*Chromosome Aberrations | 10 | 1.0 |
English Abstract | 15 | 0.0 |
Neural Conduction | 23 | 23.0 |
Mice, Nude | 2 | 0.0 |
Charcot-Marie-Tooth Disease/*diagnosis/*genetics | 5 | 83.0 |
Point Mutation | 16 | 0.0 |
X Chromosome | 6 | 1.0 |
Homozygote | 5 | 0.0 |
Myelin Sheath/pathology | 2 | 18.0 |
Charcot-Marie-Tooth Disease/*genetics/*pathology | 5 | 55.0 |
Myelin Proteins/*genetics/physiology | 3 | 60.0 |
Hereditary Motor and Sensory Neuropathies/*genetics/pathology | 2 | 25.0 |
Mice, Neurologic Mutants | 5 | 4.0 |
Mice, Transgenic | 4 | 0.0 |
Charcot-Marie-Tooth Disease/*genetics/pathology/*physiopathology | 3 | 100.0 |
Schwann Cells/pathology/physiology | 2 | 100.0 |
*Gene Expression Regulation | 2 | 0.0 |
Crossing Over, Genetic | 9 | 12.0 |
Charcot-Marie-Tooth Disease/classification/*genetics/physiopathology | 2 | 50.0 |
Brain Neoplasms/*genetics | 2 | 1.0 |
In Situ Hybridization | 2 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
DNA/*genetics | 3 | 0.0 |
Models, Genetic | 2 | 0.0 |
Biopsy | 10 | 0.0 |
Chromosomes, Human, Pair 1 | 5 | 2.0 |
*Linkage (Genetics) | 7 | 0.0 |
Nerve Fibers, Myelinated/pathology | 2 | 15.0 |
Nuclear Family | 2 | 0.0 |
Genetic Predisposition to Disease | 4 | 0.0 |
*Mutation | 12 | 0.0 |
DNA, Complementary | 3 | 0.0 |
Hereditary Motor and Sensory Neuropathies/*diagnosis/genetics | 2 | 66.0 |
Polymerase Chain Reaction/*methods | 4 | 0.0 |
Sequence Deletion | 6 | 0.0 |
Muscle, Skeletal/innervation | 2 | 22.0 |
Peripheral Nerves/*pathology | 3 | 27.0 |
Schwann Cells/pathology | 2 | 15.0 |
Chromosome Breakage/genetics | 2 | 3.0 |
Blotting, Southern | 17 | 0.0 |
Multigene Family/*genetics | 6 | 3.0 |
Chorionic Villi Sampling | 2 | 4.0 |
Interphase | 2 | 1.0 |
*Prenatal Diagnosis | 2 | 0.0 |
DNA/blood | 2 | 1.0 |
Gene Library | 3 | 0.0 |
Mental Retardation/genetics | 2 | 1.0 |
Repetitive Sequences, Nucleic Acid | 12 | 1.0 |
DNA/*analysis | 3 | 1.0 |
*Gene Rearrangement | 3 | 1.0 |
*Genes, Dominant | 2 | 0.0 |
*Genes, Recessive | 2 | 1.0 |
Age of Onset | 4 | 0.0 |
Mosaicism/*genetics | 3 | 8.0 |
Charcot-Marie-Tooth Disease/*genetics/physiopathology | 6 | 46.0 |
*Trisomy | 4 | 3.0 |
*X Chromosome | 4 | 0.0 |
*Polymerase Chain Reaction | 2 | 0.0 |
Heterozygote Detection | 4 | 0.0 |
Sex Characteristics | 2 | 0.0 |
Alleles | 5 | 0.0 |
Biological Markers | 3 | 0.0 |
Japan/epidemiology | 2 | 0.0 |
Prealbumin/genetics | 2 | 12.0 |
Multigene Family/genetics | 3 | 2.0 |
Myelin Proteins/biosynthesis/genetics | 2 | 33.0 |
DNA Primers/genetics | 2 | 0.0 |
*Apoptosis | 2 | 0.0 |
Charcot-Marie-Tooth Disease/genetics/*pathology | 2 | 33.0 |
Multigene Family | 23 | 2.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Immunoenzyme Techniques | 2 | 0.0 |
*Multigene Family | 25 | 3.0 |
Charcot-Marie-Tooth Disease/*pathology | 4 | 100.0 |
Meiosis | 2 | 1.0 |
DNA/genetics | 11 | 0.0 |
Hereditary Motor and Sensory Neuropathies/genetics | 3 | 37.0 |
Paralysis/*genetics | 4 | 33.0 |
Pressure | 2 | 1.0 |
Chromosome Disorders | 3 | 0.0 |
Karyotyping | 4 | 0.0 |
Genes, Recessive | 4 | 0.0 |
Hereditary Motor and Sensory Neuropathies/*genetics/physiopathology | 2 | 28.0 |
Asian Continental Ancestry Group | 2 | 0.0 |
Recombination, Genetic/genetics | 3 | 4.0 |
Repetitive Sequences, Nucleic Acid/genetics | 2 | 2.0 |
China | 2 | 0.0 |
Crossing Over, Genetic/genetics | 2 | 13.0 |
Charcot-Marie-Tooth Disease/*metabolism/pathology | 2 | 66.0 |
Immunohistochemistry | 6 | 0.0 |
Nerve Compression Syndromes/genetics | 3 | 75.0 |
Paralysis/genetics | 3 | 60.0 |
DNA Probes | 6 | 0.0 |
Alkyl and Aryl Transferases/*genetics | 2 | 25.0 |
Membrane Proteins/*genetics | 3 | 0.0 |
Primates | 2 | 2.0 |
Chromosome Deletion | 4 | 0.0 |
Myelin Proteins/*metabolism | 4 | 20.0 |
Schwann Cells/*metabolism/pathology | 2 | 40.0 |
Sural Nerve/metabolism/pathology | 2 | 22.0 |
Restriction Mapping | 10 | 0.0 |
Disease Susceptibility | 2 | 0.0 |
*Alkyl and Aryl Transferases | 2 | 8.0 |
Charcot-Marie-Tooth Disease/*genetics/*pathology/physiopathology | 3 | 75.0 |
*Crossing Over, Genetic | 3 | 10.0 |
Japan | 4 | 0.0 |
Autoradiography | 2 | 0.0 |
Charcot-Marie-Tooth Disease/classification/*diagnosis/*genetics | 2 | 100.0 |
Repetitive Sequences, Nucleic Acid/*genetics | 2 | 1.0 |
*Chromosome Mapping | 4 | 0.0 |
Nervous System Diseases/*genetics | 4 | 12.0 |
Italy | 5 | 0.0 |
Time Factors | 5 | 0.0 |
Charcot-Marie-Tooth Disease/classification/diagnosis/*genetics | 2 | 66.0 |
Gene Rearrangement | 2 | 0.0 |
Peripheral Nervous System Diseases/diagnosis/genetics | 2 | 100.0 |
Electrophoresis, Gel, Pulsed-Field | 7 | 3.0 |
Gene Frequency | 3 | 0.0 |
*Neural Conduction | 3 | 15.0 |
Chromosome Aberrations | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 11 | 0.0 |
*DNA Transposable Elements | 2 | 3.0 |
Chromosomes, Artificial, Yeast | 2 | 0.0 |
Microscopy, Confocal | 2 | 0.0 |
DNA | 2 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Demyelinating Diseases/*genetics | 5 | 50.0 |
*Polymorphism, Genetic | 2 | 0.0 |
Median Nerve/physiopathology | 4 | 44.0 |
Muscles/physiopathology | 2 | 18.0 |
Genes, Dominant/genetics | 2 | 1.0 |
Haplotypes/genetics | 2 | 0.0 |
Prevalence | 2 | 0.0 |
Chromosomes, Human, Pair 17/*ultrastructure | 4 | 18.0 |
Sural Nerve/pathology/ultrastructure | 3 | 33.0 |
Myelin P0 Protein | 4 | 22.0 |
Fathers | 2 | 3.0 |
*Chromosomes, Human, Pair 1 | 2 | 0.0 |
Charcot-Marie-Tooth Disease/genetics/pathology/*physiopathology | 2 | 66.0 |
*Sequence Deletion | 3 | 0.0 |
Charcot-Marie-Tooth Disease/classification/*genetics | 11 | 73.0 |
*Chromosome Disorders | 2 | 2.0 |
Chromosomes, Fungal | 3 | 4.0 |
Genome, Human | 3 | 0.0 |
Sequence Tagged Sites | 2 | 0.0 |
DNA/genetics/isolation & purification | 2 | 0.0 |
